Report Overview:
The Global Autologous Cell Therapy Product Market achieved a valuation of $11.69 Billion in 2022 and is anticipated to exceed $40.77 Billion by 2030, reflecting a compounded annual growth rate (CAGR) of 16.9% during the forecast period from 2024 to 2032.
Key Market Players:
Vericel Corporation (US), Pharmicell Co. Inc(South Korea), Holostem Terapie Avanzate...
English
Arabic
French
Spanish
Portuguese
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek